SANAI HEALTH GP announced that on November 10, 2025, the company entered into an agreement with the buyer to sell the equity of its subsidiary for approximately RMB 18.69 million, which will be settled in cash. The sale constitutes a transaction that the company must disclose, but is exempt from the requirement for shareholder approval. The highest applicable percentage for the sale exceeds 5% but is less than 25%. After the completion of the transaction, the company will no longer hold any equity in the target company, and the target company will no longer be a subsidiary of the company